Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

BLA filed for palivizumab

Dec. 24, 1997

New antibacterial agent discovered by Sankyo

Dec. 24, 1997

RD4-6250: a potential new treatment for HCV

Dec. 24, 1997

New launches for Abelcet; The Liposome Co./Wyeth-Ayerst partnership broadened

Dec. 23, 1997

FDA clears Trovan, Pfizer's broad-spectrum quinolone

Dec. 22, 1997

New antiviral agent for flu disclosed in patent literature

Dec. 22, 1997

HGS discloses new cysteine protease inhibitor

Dec. 22, 1997

Penederm and Mylan to copromote Mentax

Dec. 22, 1997

Oral neuraminidase inhibitor advances to phase II/III

Dec. 19, 1997

Daiichi's Floxin receives FDA approval

Dec. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026